TSXV - Delayed Quote • CAD
Kane Biotech Inc. (KNE.V)
At close: April 25 at 9:37 AM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,791.8830
-3,043.4720
-2,289.1900
-3,938.9700
Investing Cash Flow
-115.5180
-107.5490
-373.5450
-166.1120
Financing Cash Flow
2,274.5330
3,102.8320
2,807.9020
4,278.8770
End Cash Position
1,623.1770
1,104.9010
1,153.0900
1,007.9230
Capital Expenditure
-115.5180
-87.5490
-353.5450
-126.1120
Issuance of Capital Stock
415.2670
973.7040
--
695.4690
Issuance of Debt
2,010.0000
2,777.1600
1,796.1920
2,394.8030
Repayment of Debt
-249.5610
-527.4370
-535.8510
-21.2710
Free Cash Flow
-1,907.4010
-3,131.0210
-2,642.7350
-4,065.0820
12/31/2020 - 10/1/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SIGY Sigyn Therapeutics, Inc.
5.75
0.00%
MBIO.CN MindBio Therapeutics Corp.
0.0550
0.00%
COV.V Covalon Technologies Ltd.
0.9700
0.00%
BRAX.CN Braxia Scientific Corp.
0.0100
+100.00%
HEM.V Hemostemix Inc.
0.0400
-11.11%
THTX Theratechnologies Inc.
1.3000
-7.80%
BRTX BioRestorative Therapies, Inc.
1.2300
-3.15%
XENE Xenon Pharmaceuticals Inc.
40.10
+1.52%
TH.TO Theratechnologies Inc.
1.8000
-2.70%
ALVR AlloVir, Inc.
0.8000
+2.56%